Literature DB >> 18342222

Direct stenting for stable angina pectoris is associated with reduced periprocedural microcirculatory injury compared with stenting after pre-dilation.

Thomas Cuisset1, Michalis Hamilos, Narbeh Melikian, Eric Wyffels, Jaydeep Sarma, Giovanna Sarno, Emanuele Barbato, Jozef Bartunek, William Wijns, Bernard De Bruyne.   

Abstract

OBJECTIVES: We conducted a randomized study to compare the effect of direct stenting (DS) and conventional stenting (CS) on post-procedural index of microcirculatory resistance (IMR) values.
BACKGROUND: Direct stenting has been suggested to reduce periprocedural microcirculatory injury compared with stenting that follows pre-dilation (CS). The index of microcirculatory resistance is a sensitive invasive marker of coronary microvascular resistance.
METHODS: Fifty patients admitted for elective percutaneous coronary intervention (PCI) were included. All patients had stable angina (Canadian Cardiovascular Society class <IV) related to a lesion suitable for DS and were randomized to DS (n = 25) or CS (n = 25). Baseline demographics and clinical and procedural data were comparable in both groups. An intracoronary pressure/temperature sensor-tipped guide wire was used. Thermodilution curves were obtained at baseline and during maximal hyperemia achieved by infusion of intravenous adenosine. The index of microcirculatory resistance was calculated from the ratio of the mean distal coronary pressure at maximal hyperemia to the inverse of mean hyperemic transit time.
RESULTS: After otherwise-uneventful PCI, patients treated with CS had significantly greater IMR (DS 13 +/- 3, CS 24 +/- 14; p < 0.01) and tended to have greater post-PCI troponin T values (DS 0.035 +/- 0.04, CS 0.17 +/- 0.02; p = 0.07). In the whole sample, 20% of patients had post-PCI troponin release (troponin T >0.03 ng/ml). Patients with troponin elevation had significantly greater post-PCI IMR values than patients without troponin elevation: 24.7 +/- 13.2 versus 16.9 +/- 10.2; p = 0.04.
CONCLUSIONS: In patients undergoing successful coronary stenting for stable angina, DS is associated with reduced microvascular dysfunction induced by PCI as compared with CS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18342222     DOI: 10.1016/j.jacc.2007.11.059

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  20 in total

1.  Outcomes of direct stenting in patients with ST-elevated myocardial infarction.

Authors:  A Kalayci; V Oduncu; C Y Karabay; A Erkol; A C Tanalp; I H Tanboga; O Candan; C Gecmen; I A Izgi; C Kirma
Journal:  Herz       Date:  2017-06-14       Impact factor: 1.443

Review 2.  Coronary microvascular dysfunction: mechanisms and functional assessment.

Authors:  Paolo G Camici; Giulia d'Amati; Ornella Rimoldi
Journal:  Nat Rev Cardiol       Date:  2014-10-14       Impact factor: 32.419

Review 3.  Current developments and future applications of intracoronary hemodynamics.

Authors:  Edward Coverstone; Robert Shapiro; Jasvindar Singh
Journal:  Coron Artery Dis       Date:  2015-08       Impact factor: 1.439

4.  von Willebrand factor inhibition improves endothelial function in patients with stable angina.

Authors:  Olivier Muller; Jozef Bartunek; Michalis Hamilos; Catalina Trana Berza; Fabio Mangiacapra; Argyrios Ntalianis; Kristof Vercruysse; Christian Duby; William Wijns; Bernard De Bruyne; Guy R Heyndrickx; Marc Vanderheyden; Josefin-Beate Holz; Emanuele Barbato
Journal:  J Cardiovasc Transl Res       Date:  2012-12-12       Impact factor: 4.132

5.  Effects of Qishen Yiqi Dripping Pills () in Reducing Myocardial Injury and Preserving Microvascular Function in Patients Undergoing Elective Percutaneous Coronary Intervention: A Pilot Randomized Study.

Authors:  Gui-Xin He; Jun Xie; Hao Jiang; Wei Tan; Biao Xu
Journal:  Chin J Integr Med       Date:  2017-05-03       Impact factor: 1.978

Review 6.  Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review.

Authors:  Marco Giuseppe Del Buono; Rocco A Montone; Massimiliano Camilli; Salvatore Carbone; Jagat Narula; Carl J Lavie; Giampaolo Niccoli; Filippo Crea
Journal:  J Am Coll Cardiol       Date:  2021-09-28       Impact factor: 24.094

7.  COlchicine to Prevent PeriprocEdural Myocardial Injury in Percutaneous Coronary Intervention (COPE-PCI): Coronary Microvascular Physiology Pilot Substudy.

Authors:  Justin Cole; Nay Htun; Robert Lew; Mark Freilich; Stephen Quinn; Jamie Layland
Journal:  J Interv Cardiol       Date:  2022-05-29       Impact factor: 1.776

Review 8.  Novel antiplatelet agents: ALX-0081, a Nanobody directed towards von Willebrand factor.

Authors:  Jozef Bartunek; Emanuele Barbato; Guy Heyndrickx; Marc Vanderheyden; William Wijns; Josefin-Beate Holz
Journal:  J Cardiovasc Transl Res       Date:  2013-01-11       Impact factor: 4.132

Review 9.  Impact of Targeted Therapies for Coronary Microvascular Dysfunction as Assessed by the Index of Microcirculatory Resistance.

Authors:  James Xu; Sidney Lo; Craig P Juergens; Dominic Y Leung
Journal:  J Cardiovasc Transl Res       Date:  2020-07-24       Impact factor: 4.132

10.  Synergy between direct coronary stenting technique and use of the novel thin strut cobalt chromium Skylor™ stent: the MACE in follow up patients treated with Skylor stent [MILES Study].

Authors:  Arturo Giordano; Michele Polimeno; Nicola Corcione; Luciano Fattore; Luigi Di Lorenzo; Giuseppe Biondi-Zoccai; Paolo Ferraro; Maria Fiammetta Romano
Journal:  Curr Cardiol Rev       Date:  2012-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.